Effects of Pulsed Dye and CO2 Laser in Treatment of Hypertrophic Burn Scars.
1 other identifier
interventional
25
1 country
1
Brief Summary
A prospective, double blind, randomized controlled human clinical trial will be conducted by enrolling patients referred for laser treatment from the USAISR burn clinic. Laser candidates will be asked to participate who have an area of extremity or truncal scar measuring approximately 6cmX6cm total, in one contiguous region. The study sites, will consist of four equally sized treatment areas (3cm x 3cm), will be randomized to be treated with PDL, CO2, a combination of CO2+PDL, and an untreated control for 6 treatments. The areas will be photographed prior to each treatment and at the final visit 4-6 months after the last treatment. Color, pliability and thickness will be measured using a colorimeter, cutometer and high frequency ultrasound respectively at each appointment. Additionally, the Patient Observer Scar Assessment Scale (POSAS) will be used to score the quality of the scar, using two trained, blinded observers. The patients will also be asked on a voluntary basis for a pre-trial and post-trial 3mm punch biopsy to evaluate for the presence of histological changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2020
CompletedFirst Submitted
Initial submission to the registry
February 8, 2021
CompletedFirst Posted
Study publicly available on registry
February 24, 2021
CompletedFebruary 24, 2021
February 1, 2021
2.5 years
February 8, 2021
February 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Effectiveness of laser treatments
Using the Patient and Observer Scar Assessment Scale (POSAS), evaluate the effectiveness of Pulse Dye Laser (PDL) and Carbon Dioxide (CO2) laser treatment on symptoms related to Hypertrophic Burn Scar (HBS)
4-6 weeks post treatment
Secondary Outcomes (1)
Improvement of symptoms
4-6 weeks post treatment
Study Arms (4)
Pulse Dye Laser
EXPERIMENTALTreatment with PDL alone.
CO2 Laser
EXPERIMENTALTreatment with CO2 alone.
Combination
EXPERIMENTALTreatment with both PDL and CO2 laser.
No treatment
ACTIVE COMPARATORNo laser treatment.
Interventions
Pulse Dye laser treatment will be applied to one randomized area with the 10mm hand piece, duration of 0.45ms, and fluence of 5.25J/s.
CO2 laser treatment will be applied to one randomized area with the deep Fx hand piece, 300Hz, 15mJ, 15% density.
Pulse Dye laser and CO2 treatment will be applied to one randomized area. Pulse Dye will be applied with the 10mm hand piece, duration of 0.45ms, and fluence of 5.25J/s followed by the CO2 laser treatment with the deep Fx hand piece, 300Hz, 15mJ, 15% density.
Eligibility Criteria
You may qualify if:
- Must have at least four areas of burn scar located on the trunk or extremities measuring 3cm x 3cm and not previously treated with laser.
- Timing: There has been a minimum of 1 month after burn closure
- The subject is at least 18 years of age and not older than 65.
- Able and willing to provide verbal and written consent.
You may not qualify if:
- Active infection in experimental area
- Use of isotretinoin (Accutane) in last six months
- Life or limb-threatening injury/disease
- Prior history of non-compliance with medical regimes
- Active drug use/abuse
- Active psychiatric illness except depression (unless being treated for suicidal intentions)
- Pregnancy
- Active cancer, or new diagnosis of cancer within the past 5 years, with the exception of basal cell carcinoma, melanoma and squamous cell carcinoma, as long as the subject is disease free at the time of enrollment.
- Prior PDL or other laser treatment of the study area.
- Patient unable to tolerate laser procedure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
United States Army Institute of Surgical Research
Fort Sam Houston, Texas, 78234, United States
Related Publications (1)
Cooper LE, Nuutila K, Kemp Bohan PM, Diaz V, Batchinsky M, Carlsson AH, Cancio LC, Chan RK. Analysis of the Utility of CO2 and Pulse-Dye Lasers Together and Separately in the Treatment of Hypertrophic Burn Scars. Ann Plast Surg. 2022 Aug 1;89(2):166-172. doi: 10.1097/SAP.0000000000003240.
PMID: 35943226DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodney Chan, MD
Metis Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
February 8, 2021
First Posted
February 24, 2021
Study Start
December 19, 2017
Primary Completion
June 24, 2020
Study Completion
June 24, 2020
Last Updated
February 24, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share